Your browser doesn't support javascript.
loading
The influence of vancomycin on renal functions, the predictors and associated factors for nephrotoxicity.
Altowayan, Waleed M; Mobark, Mugahid A; ALharbi, Abdulmajed; Alduhami, Abdullah Ali; Rabbani, Syed Imam.
Affiliation
  • Altowayan WM; Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
  • Mobark MA; Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
  • ALharbi A; Department of Pathology, Faculty of Medicine, University of Kordofan, El-Obeid, Sudan.
  • Alduhami AA; Clinical Pharmacy, King Fahad Specialist Hospital, Buraydah, Qassim, Saudi Arabia.
  • Rabbani SI; Department of Pharmacy Practice, College of Pharmacy, Qassim University, Buraydah, Saudi Arabia.
PLoS One ; 18(4): e0284223, 2023.
Article in En | MEDLINE | ID: mdl-37068067
ABSTRACT

BACKGROUND:

Vancomycin has been widely used in the last six decades to treat methicillin-resistant S. aureus (MRSA) and other resistant gram-positive infections. The risk of vancomycin toxicity increases with the utilization of higher doses while treating the resistant form of bacterial infections. Nephrotoxicity is one of the major complications reported to be a hinderance in the prognosis of vancomycin therapy.

OBJECTIVES:

This hospital-based study aimed to highlight the influence of vancomycin on renal function with special emphasis on identifying the predictors and augmenting factors for nephrotoxicity.

METHODOLOGY:

A cross-sectional, unicentric, hospital-based study was conducted at King Fahad Specialist Hospital (KFSH) in Qassim region in Saudi Arabia (KSA). It included 319 hospitalized patients who received vancomycin at intermittent doses (15 to 30 mg/kg IV per day) based on the diseased state. Data regarding vancomycin dose, frequency, duration and data of renal function tests and type of admission were analysed to evaluate their influence on the renal function using parameters such as blood urea, serum creatinine levels and creatinine clearance. One-way ANOVA and Spearman correlation test were used in the analysis of data.

RESULTS:

Both male and female patients treated with vancomycin had significantly (p<0.05) elevated blood urea and serum creatinine levels compared to baseline levels while creatinine clearance was non-significantly varied. Increasing age, increasing body weight, higher vancomycin dose and trough levels, increased vancomycin frequency and duration, critically ill patients and site of infection were factors associated with significant (p<0.05) increases in blood urea and serum creatinine levels with reduction in creatinine clearance.

CONCLUSION:

Data suggested that vancomycin treatment reduced the renal function in patients and indicated its association with several predictors and confounding factors. The findings of the study might assist in identifying the patients under risk from the vancomycin-induced nephrotoxicity and in designing the preventive strategies to reduce such complications.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Renal Insufficiency / Methicillin-Resistant Staphylococcus aureus / Kidney Diseases Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Renal Insufficiency / Methicillin-Resistant Staphylococcus aureus / Kidney Diseases Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Year: 2023 Type: Article